← Back to Search

Behavioral Intervention

Nutrition Program for Childhood Obesity

Phase 2 & 3
Waitlist Available
Research Sponsored by Michigan State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from week 0 (time 1) to week 15 (time 2)
Awards & highlights
No Placebo-Only Group

Summary

This trial evaluates the 'Eat My ABCs' program, an initiative aimed at teaching healthy eating habits to low-income preschoolers in rural Michigan. The program includes fun learning activities, family engagement through letters, and a practical cookbook for parents.

Who is the study for?
This trial is for preschoolers aged 3-5 years enrolled in participating daycare classrooms, with parental consent. There are no specific exclusion criteria, so all children within this age range and setting can potentially participate.
What is being tested?
The 'Eat My ABCs' program is being tested to see if it helps improve the eating behaviors of Head Start preschoolers and positively affects their body measurements like BMI (Body Mass Index) and percent body fat.
What are the potential side effects?
Since 'Eat My ABCs' is a nutritional program rather than a medication, there aren't typical side effects. However, changes in diet may affect each child differently.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from week 0 (time 1) to week 15 (time 2)
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from week 0 (time 1) to week 15 (time 2) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Child's BMI
Percent body fat
Skin carotenoids
Secondary study objectives
Home eating environment
Household food insecurity
Parent fruit/vegetable/fiber intake
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Eat My ABCsExperimental Treatment1 Intervention
The experimental arm will receive the 14-week program including three main components: (1) "Eat My ABCs" child curriculum, (2) child fruit/vegetable letters to parents, and (3) program cookbook.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Eat My ABCs
2023
Completed Phase 3
~210

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Behavioral modification through dietary education and structured eating plans are common treatments for childhood obesity. These interventions work by teaching children and their families about healthy eating habits, portion control, and the importance of regular meals. Structured eating plans help to establish consistent eating patterns, reduce the intake of high-calorie, low-nutrient foods, and promote the consumption of fruits, vegetables, and whole grains. These strategies are crucial for childhood obesity patients as they address the root causes of unhealthy weight gain, promote long-term healthy behaviors, and can prevent the development of obesity-related health issues such as type 2 diabetes and cardiovascular diseases.

Find a Location

Who is running the clinical trial?

Michigan State UniversityLead Sponsor
198 Previous Clinical Trials
685,553 Total Patients Enrolled
Michigan Health Endowment FundOTHER
4 Previous Clinical Trials
388 Total Patients Enrolled

Media Library

Eat My ABCs (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05780008 — Phase 2 & 3
Healthy Nutrition Research Study Groups: Eat My ABCs
Healthy Nutrition Clinical Trial 2023: Eat My ABCs Highlights & Side Effects. Trial Name: NCT05780008 — Phase 2 & 3
Eat My ABCs (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05780008 — Phase 2 & 3
~69 spots leftby Dec 2025